BRCC3 and breast carcinoma: Previous report has demonstrated that abrogation of BRCC3 (BRCC36) using small interfering RNAs targeting BRCC36 causes no significant effect on the cell apoptosis of human breast cancer cell lines, suggesting that the downregulation of BRCC3 expression is not lethal [27].